Jetfall™, is an innovative carbon dioxide (“CO₂”) angiographic injector and accessories and the first of its kind in the PRC. Jetfall™, is an innovative CO₂ angiographic device designed for vascular imaging of the peripheral venous system and arteries below the diaphragm. It is particularly suitable for patients who are allergic to iodine-based contrast agents, have renal insufficiency, hyperthyroidism, or severe heart failure, and for elderly or diabetic patients at higher procedural risk, as well as others requiring vascular imaging examinations. By offering convenient usage and enhanced safety for patients with conditions such as iodine allergy, hyperthyroidism, and renal insufficiency, Jetfall™ addresses a significant unmet need.

The JetfallAngio™- Medical CO₂ Management and Transfer System is a manual, non-patient-contacting medical gas connection, pressure monitoring and volume control system. It connects to a CO₂ gas line, monitors gas pressure and transfers a preset volume of medical gas to interventional diagnostic devices only. It is not for direct gas delivery into the human body or laparoscopic insufflation. The unit is equipped with pressure tubing and accessories. This product is Class I, 510(k) exempt pursuant to 21 CFR 868.1870 and 21 CFR 868.5860, subject to limitations in 21 CFR 868.9.

AMSorb™ is a bioresorbable coronary stent fabricated from medical-grade Poly-L-lactic acid (“PLLA”) polymer utilizing our proprietary 3D-MAP technology, intended for use in PCI procedures to treat obstructive coronary artery disease. Under the 3D-MAP technology, the stent is engineered with round struts featuring circular cross-sections to optimize the stent apposition, enabling smoother embedment into the vessel wall and reducing effective strut thickness compared with conventional laser-cut rectangular struts. This geometric profile delivers hemodynamic benefits by minimizing blood flow disturbance and mechanical damage to blood cells, thereby accelerating endothelialization and reducing the risk of thrombosis while the PLLA matrix undergoes hydrolytic resorption to preserve natural vessel vasomotion.

PERISORB™ is a pioneering, fully bioresorbable, drug-eluting peripheral vascular stent fabricated from poly (l-lactide-co-ε-caprolactone) (“PLCL”) polymer utilizing our proprietary 3D-MAP technology, specifically indicated for the treatment of SFA stenosis or occlusion resulting from LEAD. Under the 3D-MAP technology, the configured stent structure balances radial strength and flexibility to navigate complex, tortuous, or heavily calcified lesions for precise placement, while the bioresorbable PLCL matrix supports the vessel to eliminate permanent metallic implant risks and the necessity for lifelong antiplatelet therapy.